Your browser is no longer supported. Please, upgrade your browser.
Settings
STTK [NASD]
Shattuck Labs, Inc.
Index- P/E- EPS (ttm)- Insider Own1.00% Shs Outstand41.77M Perf Week-9.38%
Market Cap1.12B Forward P/E- EPS next Y-1.65 Insider Trans-45.54% Shs Float32.54M Perf Month2.84%
Income- PEG- EPS next Q-0.35 Inst Own56.70% Short Float3.70% Perf Quarter-26.08%
Sales9.23M P/S121.36 EPS this Y-274.80% Inst Trans3.28% Short Ratio6.64 Perf Half Y-31.64%
Book/sh7.15 P/B3.85 EPS next Y-21.30% ROA- Target Price- Perf Year-
Cash/sh7.90 P/C3.49 EPS next 5Y- ROE- 52W Range17.51 - 60.52 Perf YTD-47.43%
Dividend- P/FCF- EPS past 5Y- ROI-11.90% 52W High-54.48% Beta-
Dividend %- Quick Ratio18.50 Sales past 5Y- Gross Margin- 52W Low57.34% ATR2.14
Employees59 Current Ratio18.50 Sales Q/Q-76.80% Oper. Margin- RSI (14)46.20 Volatility6.82% 7.47%
OptionableNo Debt/Eq0.00 EPS Q/Q55.10% Profit Margin- Rel Volume1.41 Prev Close28.48
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume181.20K Price27.55
Recom1.80 SMA201.04% SMA50-6.26% SMA200-20.97% Volume255,191 Change-3.27%
Apr-14-21Initiated Berenberg Buy $47
Jan-11-21Initiated Evercore ISI Outperform
Nov-03-20Initiated Needham Buy $34
Nov-03-20Initiated Cowen Outperform
Nov-03-20Initiated Citigroup Buy $36
Jun-01-21 10:44AM  
May-10-21 07:00AM  
Apr-30-21 05:33PM  
Apr-28-21 04:45PM  
Apr-26-21 09:05AM  
Apr-12-21 10:33AM  
07:00AM  
Apr-06-21 07:00AM  
Mar-16-21 10:28AM  
07:00AM  
Mar-15-21 04:45PM  
Mar-11-21 08:28AM  
Feb-23-21 06:40PM  
Feb-12-21 09:41AM  
Jan-12-21 05:32AM  
Jan-07-21 05:27PM  
Jan-06-21 08:23AM  
Dec-18-20 06:42PM  
Nov-25-20 04:30PM  
Nov-13-20 06:00AM  
Nov-11-20 09:27AM  
Nov-06-20 08:00AM  
Nov-05-20 08:00AM  
Oct-29-20 08:30AM  
Oct-23-20 05:54PM  
Oct-21-20 06:19PM  
Oct-09-20 03:49PM  
01:28PM  
11:20AM  
Oct-08-20 07:55PM  
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hornblower JosiahDirectorJun 11Sale29.414,392129,1693,128,751Jun 11 07:18 PM
Hornblower JosiahDirectorJun 10Sale28.675,316152,3903,133,143Jun 11 07:18 PM
Hornblower JosiahDirectorJun 09Sale29.217,601222,0213,138,459Jun 11 07:18 PM
Hornblower JosiahDirectorJun 08Sale29.729,229274,3173,146,060Jun 08 07:42 PM
Hornblower JosiahDirectorJun 07Sale29.4510,736316,1833,155,289Jun 08 07:42 PM
Hornblower JosiahDirectorJun 04Sale28.577,047201,3603,166,025Jun 08 07:42 PM
Hornblower JosiahDirectorJun 03Sale27.305,494150,0073,173,072Jun 03 06:24 PM
Hornblower JosiahDirectorJun 02Sale27.646,399176,8883,178,566Jun 03 06:24 PM
Hornblower JosiahDirectorJun 01Sale27.415,931162,5533,184,965Jun 03 06:24 PM
Hornblower JosiahDirectorMay 28Sale27.188,747237,7063,190,896May 28 06:02 PM
Hornblower JosiahDirectorMay 27Sale26.374,923129,8293,199,643May 28 06:02 PM
Hornblower JosiahDirectorMay 26Sale24.745,320131,6393,204,566May 28 06:02 PM
Hornblower JosiahDirectorMay 25Sale24.875,159128,2953,209,886May 25 06:57 PM
Hornblower JosiahDirectorMay 24Sale25.235,456137,6473,215,045May 25 06:57 PM
Schreiber TaylorChief Executive OfficerMay 21Sale25.3610,545267,3922,610,750May 25 06:59 PM
Hornblower JosiahDirectorMay 21Sale25.585,977152,8673,220,501May 25 06:57 PM
Hornblower JosiahDirectorMay 20Sale26.207,532197,3113,226,478May 20 08:30 PM
Schreiber TaylorChief Executive OfficerMay 20Sale26.197,378193,2052,621,295May 20 08:36 PM
Hornblower JosiahDirectorMay 19Sale24.657,747191,0003,234,010May 20 08:30 PM
Schreiber TaylorChief Executive OfficerMay 19Sale24.637,794191,9642,628,673May 20 08:36 PM
Hornblower JosiahDirectorMay 18Sale26.035,107132,9343,241,757May 20 08:30 PM
Schreiber TaylorChief Executive OfficerMay 18Sale26.054,998130,1932,636,467May 20 08:36 PM
Thomson Erin AtorGeneral CounselMay 17Sale26.254,000104,98291,259May 17 09:10 PM
Neill Andrew RChief Financial OfficerMay 17Sale26.272,00052,54257,963May 17 09:08 PM
Schreiber TaylorChief Executive OfficerMay 17Sale26.286,139161,3352,641,465May 17 09:07 PM
Hornblower JosiahDirectorMay 17Sale26.306,336166,6593,246,864May 17 09:06 PM
Schreiber TaylorChief Executive OfficerMay 14Sale26.2511,077290,7572,647,604May 17 09:07 PM
Hornblower JosiahDirectorMay 14Sale26.2411,095291,0933,253,200May 17 09:06 PM
Schreiber TaylorChief Executive OfficerMay 13Sale25.919,856255,4012,658,681May 17 09:07 PM
Hornblower JosiahDirectorMay 13Sale25.8810,090261,1033,264,295May 17 09:06 PM
Neill Andrew RChief Financial OfficerMay 12Option Exercise0.018,8608959,963May 12 08:38 PM
Schreiber TaylorChief Executive OfficerMay 12Sale27.2914,242388,6372,668,537May 12 08:35 PM
Hornblower JosiahDirectorMay 12Sale27.2714,057383,3463,274,385May 12 08:33 PM
Schreiber TaylorChief Executive OfficerMay 11Sale28.0314,783414,3412,682,779May 12 08:35 PM
Hornblower JosiahDirectorMay 11Sale28.0415,040421,6673,288,442May 12 08:33 PM
Schreiber TaylorChief Executive OfficerMay 10Sale26.988,188220,9492,697,562May 12 08:35 PM
Hornblower JosiahDirectorMay 10Sale26.948,227221,6233,303,482May 12 08:33 PM
Neill Andrew RChief Financial OfficerApr 28Sale35.0020,000700,00051,103Apr 30 05:00 PM
Thomson Erin AtorGeneral CounselApr 28Sale35.005,000175,00095,259Apr 30 05:00 PM
Neill Andrew RChief Financial OfficerApr 15Sale30.7424,000737,76071,103Apr 19 06:16 PM
Thomson Erin AtorGeneral CounselApr 15Sale30.777,000215,390100,259Apr 19 06:12 PM
Pandite Arundathy N.Chief Medical OfficerJan 05Option Exercise0.011,60416101,907Jan 19 07:50 PM
Neill Andrew RSee RemarksDec 22Option Exercise0.014,4264495,103Dec 28 04:47 PM
Neill Andrew RSee RemarksNov 05Option Exercise0.012,2112290,677Nov 09 04:30 PM
Thomson Erin AtorGeneral CounselNov 05Option Exercise0.012,95230107,259Nov 09 04:30 PM
Redmile Group, LLCDirectorOct 14Buy17.343,441,17659,669,3435,619,914Oct 15 05:21 PM